A collaborative effort by cancer researchers and chemists has resulted in the identification of a new drug target in leukemia and creation of a candidate drug that hits the target. More important, the research demonstrates a new, highly accurate way of proving how this and certain other classes of drugs work -- extremely valuable information in the risky business of drug development.
No comments:
Post a Comment